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8Summary
Salmonella enterica serovar Typhimurium is a common cause of gastroenteritis
in humans and, occasionally, also causes systemic infection. During systemic
infection an important characteristic of Salmonella is its ability to survive and
replicate within macrophages (M?). The outer membrane protease PgtE of S.
enterica is a member of the omptin family of outer membrane aspartate
proteases, which are ?-barrel proteins with five surface-exposed loops. The main
goals of this study were to characterize biological substrates and pathogenesis-
associated functions of PgtE and to determine the conditions where PgtE is fully
active.
In this study we found that PgtE requires rough lipopolysaccharide (LPS) to be
functional but is sterically inhibited by the long O-antigen side chain in smooth
LPS. Salmonella isolates normally are smooth with a long oligosaccharide O-
antigen, and PgtE remains functionally cryptic in wild-type Salmonella
cultivated in vitro. Interestingly, our results showed that due to increased
expression of PgtE and to reduced length of the LPS O-antigen chains, the wild-
type Salmonella expresses highly functional PgtE when isolated from mouse
M?-like J774A.1 cells. Salmonella is thought to be continuously released from
M?s to infect new ones, and our results suggest that PgtE is functional during
these transient extracellular growth phases.
Six novel host protein substrates were identified for PgtE in this work. PgtE was
previously known to activate human plasminogen (Plg) to plasmin, a broad-
spectrum serine protease, and in this study PgtE was shown to interfere with the
Plg system by inactivating the main inhibitor of plasmin, alpha2-antiplasmin.
PgtE also interferes with another important proteolytic system of mammals by
activating pro-matrix metalloproteinase-9 to an active gelatinase. PgtE also
directly degrades gelatin, a component of extracellular matrices. PgtE also
increases bacterial resistance against complement-mediated killing in human
serum and enhances survival of Salmonella within murine M?s as well as in the
liver and spleen of intraperitoneally infected mice.
Taken together, the results in this study suggest that PgtE is a virulence factor of
Salmonella that has adapted to interfere with host proteolytic systems and to
9modify extracellular matrix; these features likely assist the migration of
Salmonella during systemic salmonellosis.
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1. Introduction: Pathogenesis of Salmonella infections
Salmonellosis causes over 3 million deaths every year and is economically the
most important foodborne disease world-wide (Pang et al, 1995). The genus
Salmonella contains two species: Salmonella enterica that is pathogenic to
warm-blooded animals and Salmonella bongori that is rarely associated with
infectious diseases in humans. Salmonella is genetically related to Escherichia
coli and their genomic sequences are approximately 80 % identical (McClelland
et al,  2001).  It  has  been estimated that E. coli and Salmonella diverged from a
common ancestor some 120 million years ago after which they have gained
numerous phenotypic characteristics that distinguish these enteric species from
each other (Ochman and Wilson, 1987). Salmonella has acquired fourteen large
genomic insertions, Salmonella pathogenicity islands 1 to 14 (SPI-1 to SPI-14)
that encode many genes important for virulence of Salmonella (Morgan, 2007).
SPI-1 was acquired very early in the evolution of Salmonella and both S.
enterica and S. bongori possess it. SPI-2, on the other hand, is only present in S.
enterica and  was  acquired  by  this  species  after  its  divergence  from S. bongori
(Groisman and Ochman, 1997). Based on comparative genomics and biotyping
(Crosa et al, 1973; LeMinor and Popoff, 1987)), S. enterica has been divided
into 6 subspecies and 2519 serovars (sv) (Popoff et al, 2004). Subspecies I
includes 99% of the serovars that are pathogenic to mammals and cause diseases
varying from self-limiting gastroenteritis to systemic bacteremia (Chan et al,
2003). In humans, S. enterica sv Typhimurium and sv Enteritidis are the most
common causes of gastroenteritis, and also cause systemic infection in
approximately 5% of infected individuals (Hohmann, 2001). A more severe
Salmonella-infection, with a mortality of 10-15% without treatment, is typhoid
fever caused by sv Typhi (Ohl and Miller, 2001). In a murine host,
Typhimurium infection resembles human typhoid fever, and therefore mouse
models are widely used to study pathogenesis of systemic Salmonella infections.
Salmonella infections begin with ingestion of bacteria in contaminated food or
water. A fraction of Salmonella cells survive the low pH of the stomach and
reach the small intestine, where they replicate and colonize. Salmonella
penetrates  the  intestinal  mucus  layer  of  the  small  bowel  and  adheres  to  the
intestinal epithelium. Salmonella traverses  to  the  basolateral  side  of  the
epithelium. Salmonella-mediated invasion of the epithelium in the small
intestine occurs preferably via antigen-sampling M-cells that overlie the Peyer´s
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patches, but also via the nonphagocytic enterocytes. The invasion process
requires the type three secretion system (TTSS) and effector proteins encoded by
SPI-1 (Ohl and Miller, 2001). After invasion into the epithelial cells,
gastroenteritis-causing Salmonella induces a  fluid secretion in the intestine and
initiates transmigration of neutrophils into the intestinal lumen (Galyov et al,
1997; McGovern and Slavutin, 1979). These events cause diarrhea which is one
of the symptoms in salmonellosis (Giannella, 1979).
Once across the epithelium, Salmonella initiates systemic infection by entering
submucosal macrophages (M?) and dendritic cells (DC) by host-cell mediated
phagocytosis  as  well  as  by Salmonella-induced macropinocytosis. Survival
inside phagocytic cells is crucial for Salmonella during systemic infection, and it
has been shown that Salmonella mutants unable to survive inside macrophages
are avirulent (Fields et al, 1986). Intracellular Salmonella disseminates from the
gut to the organs of the reticuloendothelial system, such as the liver and the
spleen, where the bacteria are mainly associated with M?s and DCs (Richter-
Dahlfors et al, 1997).
At some point during the infection, Salmonella induces cell death in M?s (Chen
et al, 1996; Hueffer and Galán, 2004; Knodler and Finlay, 2001; Lindgren et al,
1996; Richter-Dahlfors et al, 1997) and this way escapes from the host cell and
may spread to new ones. The infected, apoptotic cells are also targeted for
engulfment by other macrophages and this way Salmonella spreads directly from
one cell to another (Guiney, 2005). Sheppard et al (2003) have shown that
during acute infection, the number of Salmonella cells in an individual
phagocyte is low, with the majority of the phagocytes containing only one
bacterium. They hypothesized that in tissues Salmonella replicates intracellularly
in pathological lesions and that bacterial growth mainly results from an increase
in the number of infected phagocytes. It follows that at some point during the
infection Salmonella escapes from infected phagocytes to infect new ones and to
disseminate to secondary infection sites. This way, the amount of lesions also
increases as the infection proceeds. The repeated escape from the host cells and
the infection of new ones are crucial for full spread within the host and the
virulence of Salmonella (Mastroeni and Sheppard 2004).
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2. Interaction of Salmonella with macrophages and
dendritic cells
M?s and DCs are Trojan horses in systemic Salmonella infections  as
Salmonella survives and replicates within these phagocytic cells that normally
are critical for innate immunity and the acquired antibacterial responses.
Professional phagocytes include the circulating monocytes and the resident M?s
in  tissues,  such  as  Kupffer  cells  in  the  liver.  M?s are also found in mucosal
structures such as the submucosal M?s  in  the  Peyer’s  patches  of  the  small
intestine. They are important in many biological functions such as development,
tissue remodeling, immune responses and inflammation (Aderem and Underhill,
1999) and effectively recognize, internalize and degrade microbes, apoptotic
host cells and inert particles (Méresse et al, 1999). Another cell group that is
important in systemic Salmonella infection is the antigen-presenting DCs. They
are found in almost all peripheral tissues as well as in primary (thymus and bone
marrow) and secondary (lymph nodes, Peyer’s patches, spleen) lymphoid
organs. Their function is to collect and present antigenic material to the
lymphocytes (Bonasio and von Andrian, 2006).
Phagocytosis of microbes is a complex mechanism, which in the phagocytes is
mediated by a combination of different surface receptors, such as complement
receptors that mediate internalization of complement-opsonized microbes and
Fc-receptors that mediate internalization of antibody-opsonized microbes
(Aderem and Underhill, 1999; Ravetch, 1997; Underhill and Ozinsky, 2002).
Salmonella also actively invades phagocytes utilizing effector proteins
translocated by SPI-1 TTSS (Mèresse et al, 1999; Drecktah et al, 2006). Once
internalized, Salmonella persists and multiplies in a Salmonella containing
vacuole (SCV; Alpuche-Aranda et al, 1994). SCV avoids fusion with late
endosomes and lysosomes (Hashim, et al, 2000; Holden, 2002; Brumell and
Grinstein, 2004; Buchmeier and Heffron, 1991) and Salmonella directs the
maturation of SCV by a SPI-2 dependent fashion. The SPI-2 encoded protein
SpiC inhibits the fusion of SCV with lysosomes and endosomes (Uchiya et al,
1999) and another SPI-2 gene product, SifA, is required for the SCV membrane
integrity (Beuzón et al, 2000; Holden, 2002; Waterman and Holden, 2003).
Conventional phagolysosome is very antimicrobial and contains, for example,
reactive oxygen and nitrogen species and cationic antimicrobial peptides
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(CAMP) that effectively kill bacteria (Linehan and Holden, 2003). Salmonella
senses the conditions within SCV and activates transcription of the virulence
genes, which protect it against the antimicrobial effectors in M?s. SPI-2 TTSS
encodes several enzymes that directly inactivate reactive oxygen and nitrogen
molecules. The PhoP/Q two-component regulatory system, on the other hand,
activates expression of components that protect Salmonella against antimicrobial
peptides (Ohl and Miller, 2001).
Besides actively invading through the epithelium of the small intestine,
Salmonella can also traverse the epithelial barrier within CD18-positive
phagocytes (Vazquez-Torres et al, 1999). The migration of Salmonella from the
gastrointestinal tract into the liver and spleen has been shown to mainly take
place  inside  M?s and DCs (Vazquez-Torres et al, 1999) and is most likely
dependent on host cell-mediated proteolytic activity. Interestingly, gentamicin,
which poorly penetrates eukaryotic cells, reduces bacterial loads in mice infected
with Salmonella, which indicates that a proportion of Salmonella cells are, at
least transiently, outside the phagocytes (Bonina et al, 1998). Further, in typhoid
fever, one third of the bacteria in patient blood are found outside phagocytic
cells (Wain et al, 1998), suggesting that Salmonella disseminates also
extracellularly and, therefore, is likely to require bacterial proteolytic activity.
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3. The outer membrane protein PgtE of Salmonella
enterica
During the growth of S. enterica sv Typhimurium in SCV in a mouse M?-like
cell line J774A.1, the gene expression of Salmonella goes through significant
changes and, for example, the transcription of the pgtE gene of Typhimurium is
upregulated and is five to ten times higher than in bacteria cultivated in the cell
culture medium (Eriksson et al, 2003; Eriksson-Ygberg et al, 2006). The pgtE
gene  is  present  and  is  98  %  identical  in  all  fully  or  partially  sequenced
chromosomes of S. enterica but, so far, the functions of the PgtE surface
protease that it encodes have only been studied with Typhimurium.
3.1 The omptin family of bacterial surface proteins
PgtE of S. enterica is a member of the omptin family of outer membrane
aspartate proteases in Gram-negative bacteria. The biological functions and
virulence potential of the omptins have been characterized for some members of
the  family,  in  particular  for  Pla  of Yersinia pestis (Kukkonen and Korhonen,
2004). Pla has a central role in the virulence of Y. pestis, whereas the virulence
roles of the other omptins, including PgtE, have remained less clear. Expression
of Pla activity is associated with the invasive character of plague; deletion of pla
increased the LD50 of Y. pestis from 50 to approximately 107 bacteria in a
subcutaneous infection model in mice. No effect of the pla deletion was detected
in an intravenous infection model (Sodeinde et al, 1992). These results indicate
that Pla enables the spread of Y. pestis from the subdermal infection site into the
lymph nodes and the circulation. More recently, Sebbane et al (2006a; 2006b)
showed that the pla gene is needed for the establishment of bubonic plague by Y.
pestis and is one of the most highly expressed genes in bacteria in the bubo.
Y. pestis Pla activates the mammalian plasma proenzyme plasminogen (Plg) into
the broad-spectrum serine protease plasmin. Plg is a 90-kDa glycoprotein that
circulates in plasma in high concentration (2?M) and also is present in other
body fluids and within the extracellular matrix (ECM; Stephens and Vaheri,
1993). Plg is activated to plasmin by a proteolytic cleavage of the site Arg561-
Val562 by two mammalian Plg activators, tissue-type Plg activator (tPA) and
urokinase-type Plg activator (uPA) (Myöhänen and Vaheri, 2004). Pla resembles
the mammalian Plg activators in activating Plg by a cleavage of the same peptide
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bond. Also other invasive human pathogens, streptococci and staphylococci,
express Plg activators. Streptokinase and staphylokinase are secreted non-
enzymatic Plg activators that form molecular complexes with Plg and plasmin
leading to the changes in conformation and specificity of Plg and plasmin
(Rabijns et al, 1997; Wang et al, 1998). Plasmin has a central role in fibrinolysis
(Collen and Lijnen, 1991), and it also degrades non-collagenous components of
the ECM and activates pro-matrix metalloproteinases (proMMPs) (Liotta et al,
1981; Saksela, 1985; Carmeliet et al, 1997). Pla proteolytically inactivates the
main physiological inhibitor of plasmin, alpha2-antiplasmin (?2AP) (Kukkonen
et al, 2001) which is a 70 kDa serine protease inhibitor and circulates in plasma
at a concentration of 60-70 ?g/ml. ?2AP is  a  fast  inhibitor  of  free plasmin and
forms  an  equimolar  complex  with  plasmin  in  a  two-stage  process;  first  in  a
reversible fashion and then with a covalent bonding between the ??AP reactive
site and the active site of plasmin (Coughlin, 2005). Pla-mediated Plg activation
and ?2AP inactivation result in an uncontrolled plasmin-mediated proteolysis.
Further, Y. pestis Pla mediates bacterial binding to laminin and heparan sulfate
proteoglycans that are major components of basement membranes (BM), and to
mouse BM and human epithelial cell-derived ECM (Lähteenmäki et al, 1998;
2001b). Pla-mediated Plg activation and ?2AP inactivation promote damage of
BM  and  ECM in vitro (Lähteenmäki et al, 2000; 2005). Migrating eukaryotic
cells and many bacterial pathogens that cause systemic infections utilize host
proteolytic systems to break tissue barriers and to potentiate cell metastasis
(Lähteenmäki et al, 2001a; 2005; Mignatti and Rifkin, 1993; Travis et al, 1995;
Vassalli et al, 1992); this may apply to Pla-positive bacteria as well.
Pla also enhances bacterial invasiveness into human epithelial and endothelial
cells (Cowan et al, 2000; Lähteenmäki et al, 2001b) and Pla-mediated invasion
into HeLa cells has been shown to involve intracellular signalling and
cytoskeletal rearrangement of the host cell (Benedek et al, 2004). Pla also
degrades the complement component C3 (Sodeinde et al, 1992). Taken together,
Pla is an astonishingly multifunctional virulence factor that functions in
proteolysis, adhesion and invasion.
The members of the omptin family are orthologs with approximately 50-70 %
sequence identity. Their mature forms have 290-301 amino acids and lack or
have a low content of cysteine (Kukkonen and Korhonen, 2004; Fig 1). They
cleave polypeptides after basic residues (Dekker et al, 2001). The structure of
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OmpT of E. coli has been solved by crystallography (Vandeputte-Rutten et al,
2001). It is a ?-barrel protein with 10 anti-parallel ?-strands connected by four
periplasmic turns and five surface-exposed loops. The catalytic residues (Asp83,
Asp85, Asp210 and His212) reside in a negatively charged cleft surrounded by
the five surface-exposed loops (L1-L5; Vandeputte-Rutten et al, 2001).
Activation of OmpT into an enzymatically active form was seen with E. coli K-
12 lipopolysaccharide (LPS) and probably leads to a subtle conformational
change in the omptin structure (Kramer et al, 2000; 2002). The crystal structure
of a ferrichrome-iron receptor FhuA, which is a ?-barrel outer membrane protein
of E. coli, has been solved in complex with LPS (Coulton et al, 1986; Ferguson
et al, 1998). The three-dimensional structure shows that FhuA non-covalently
binds a single LPS molecule. An LPS-binding motif of four basic amino acids
was identified in FhuA and subsequently detected in several prokaryotic and
eukaryotic LPS-binding proteins (Ferguson et al, 2000). OmpT has three basic
amino acids (Arg138, Arg175 and Lys226) of the motif in the correct spatial
organization (Vandeputte-Rutten et al, 2001). PgtE has two arginines (Arg138
and Arg171) of the motif (Fig 1).
Figure 1. The surface protease
PgtE of S. enterica. The structure
of PgtE was modelled based on the
coordinates of the OmpT crystal
structure (ExPDB1I78; Vandeputte-
Rutten et al, 2001) and the figure
was drawn using Swiss-Pdb viewer
(Guex and Peittsch, 1997;
http://www.expasy.org/spdbv/).
The catalytic residues Asp84,
Asp86, Asp206 and His208, the
residues Arg138 and Arg171 of the
LPS binding motif, and two girdles
of aromatic residues that border the
outer membrane are indicated.
Sodeinde and Goguen (1989) found that PgtE activates mammalian Plg to
plasmin when expressed from a multi-copy plasmid in recombinant E. coli.
However, they did not detect PgtE-mediated Plg activation in wild-type isolates
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of Typhimurium (Sodeinde and Goguen, 1989). Guina et al (2000) have shown
that PgtE degrades ?-helical CAMPs, which suggests that PgtE may have a role
in bacterial resistance to innate immunity. In a vaccine study, PgtE was found to
degrade viral epitopes that were fused into fimbriae of an attenuated
Typhimurium strain, and deletion of pgtE resulted in a higher antibody response
against the viral epitopes (Chen and Schifferli, 2003). These studies suggest that
PgtE is able to cleave various types of substrates. However, the biological
functions and significance of PgtE in virulence of S. enterica have not been
systemically addressed.
PgtE resembles Pla in that it activates Plg, whereas OmpT is dramatically less
active towards this substrate (Sodeinde and Goguen 1989; Kukkonen et al,
2001). Substitution of critical surface-exposed amino acids converted OmpT into
a Pla-like enzyme (Kukkonen et al, 2001), which indicates that the differing
substrate specifities in omptin proteolysis are dependent on their surface loop
structures.
3.2 The PhoP/Q two-component regulatory system in regulation of PgtE
and other outer membrane components of Salmonella
Transcription of the pgtE gene of Salmonella is under the control of the PhoP/Q
two-component regulatory system (Guina et al, 2000; Bader et al, 2003). The
PhoP/Q system regulates expression of c. 40 genes, including at least 15 genes
encoding outer membrane components. The PhoP/Q system is important in
intramacrophage survival of Salmonella (Fields et al, 1986), in bacterial
resistance to antimicrobial peptides and acidic pH (Fields et al, 1989; Foster and
Hall, 1990; Groisman et al, 1992), in bacterial invasion into epithelial cells
(Behlau and Miller, 1993), in formation of SCV (Alpuche-Aranda et al, 1994)
and in reduction of the presentation of antigens by phagocytic cells (Wick et al,
1995). It has also been shown that the PhoP/Q system has a role in Salmonella-
induced human macrophage cell death (Detweiler et al, 2001) and that a
Typhimurium mutant constitutively expressing PhoP has a reduced amount of
O-antigen which is the outermost part of the LPS (Guo et al, 1997; Baker et al,
1999).
The PhoP/Q system consists of the inner membrane sensor/kinase PhoQ and the
cytoplasmic response regulator PhoP. The PhoP/Q system responds to the levels
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of Mg2+ and  Ca2+ ions  and  to  CAMPs  in  the  periplasmic  space  of Salmonella
cells (Bader et al, 2003; 2005; García Véscovi et al, 1996; Groisman, 2001).
Growth of bacteria in millimolar concentrations of Mg2+ represses expression of
the PhoP-activated genes, whereas the growth in micromolar concentrations of
Mg2+ activates their expression. Ca2+ also is a physiologically relevant cation in
regulation of the PhoP/Q system and high Ca2+ concentration represses
transcription of PhoP-activated genes (García Véscovi et al, 1996). More
recently, Bader et al (2003) reported that the PhoP/Q system senses sublethal
concentrations of CAMPs. Bader et al (2005) have also shown that CAMPs act
as the activating signals for the PhoP/Q system whereas the divalent cations
repress the system by competitive inhibition of CAMP binding to PhoQ. They
suggest that CAMPs displace the divalent cations from cation-binding sites in
PhoQ and this way activate the PhoP/Q system inside SCVs.
Expression of the PhoP-activated genes is high in the SCV, where pH is acidic,
the amounts of Mg2+ and Ca2+ ions are low and the concentration of CAMPs is
high (Alpuche-Aranda et al, 1992; Bader et al, 2005). Some of the genes that are
activated by the PhoP/Q system are also dependent on another two-component
system, PmrA-PmrB (Roland et al,  1993).  The  PmrA/B  system  can  either  be
activated by the PhoP/Q system or by extracellular acidification (Soncini and
Groisman, 1996). Thus, the expression of the genes that are under the control by
the  PhoP/Q  or  the  PmrA/B  systems  can  be  activated  by  a  spectrum  of
environmental signals. Recently, it was shown that the upregulation of pgtE by
the PhoP/Q system is indirect and mediated by a PhoP-regulated transcriptional
regulator SlyA (Navarre et al, 2005). Taken together, the regulation of gene
expression in Salmonella is complex and dependent on various regulatory
systems.
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4. Lipopolysaccharide variability and modification in
Salmonella
LPS is a major component of the outer leaflet of the outer membrane in Gram-
negative bacteria. The LPS molecule consists of the endotoxic lipid A, the
oligosaccharide core (further divided into the inner and the outer cores) and the
O-specific side chain (O-antigen) that is composed of repeating oligosaccharide
units (Raetz and Whitfield, 2002). The lipid A and the inner core are highly
conserved within Enterobacteriaceae (Heinrichs et al, 1998, Bruneteau and
Minka, 2003), whereas the O-antigens are remarkably diverse (Raetz and
Whitfield, 2002). The O-antigen is a major factor in antigenic variability of the
Salmonella cell surface and S. enterica has been divided into 46 O-serogroups
based on differences in the O-antigen (Wang et al, 2002). Smooth LPS with long
O-antigen is important virulence factor of pathogenic Salmonella isolates and
protects Salmonella against complement-mediated killing in serum (Joiner et al,
1982; Murray et al, 2003; Yethon et al, 2000).
Many PhoP/Q-regulated genes function in the remodelling of the LPS during the
growth of Salmonella within  M?s (Ernst et al, 2001). Further, Wzz-proteins
control the length and density of the O-antigen and are important for the serum
resistance as well as for the interaction of Salmonella with  M?s. WzzST is
required for the polymerization of the O-antigen with 16-35 serotype-specific
oligosaccharide units of 3-4 carbohydrate moieties and WzzfepE for
polymerization of the O-antigen with over 100 oligosaccharide units (Murray et
al, 2003; 2005; 2006). Murray et al (2006) suggested that an O-antigen with
over 100 oligosaccharide units protects Salmonella against complement-
mediated killing more efficiently than does a shorter O-antigen. On the other
hand, Murray et al (2006) showed that Salmonella with a shorter O-antigen are
phagocytosed more effectively by M?s. This is also supported by the result that
rough Salmonella isolates lacking the O-antigen are taken up by phagocytes
more efficiently than smooth Salmonella (Wick et al, 1994). Taken together, it
might be that the bimodal O-antigen length is advantageous for Salmonella
during different stages of infection. Interestingly, inside the murine M?s, the
three main gene clusters acting in the LPS biosynthesis (Reeves et al, 1996),
wecDE (genes required for the oligosaccharide synthesis and processing), waa
(genes required for the biosynthesis of the core region) and rfb (many of the
genes required for the synthesis of O-antigen) are downregulated (Eriksson et al,
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2003, Eriksson-Ygberg et al, 2006). However; it is not known whether
expression of wzzST and wzzfepE genes is modified inside M?s.
Changes in the LPS structure may prevent the interaction of the positively
charged CAMPs with the negatively charged lipid A and this way promote the
resistance of Typhimurium against CAMPs (Ernst et al, 2001). PagP, for
example, is a PhoP-activated gene product and required for the addition of
palmitate to lipid A (Guo et al, 1998), which decreases the permeability of the
outer membrane and promotes the bacterial resistance to CAMPs. The
pmrE/prmF operon, on the other hand, is regulated by the PmrA/B and PhoP/Q
systems. PmrE and PmrF mediate the substitution of lipid A with cationic
aminoarabinose and ethanolamine and this way mask negative charges of the
core and the lipid A and reduce the affinity of the positively charged
antimicrobial peptides to the bacterial surface (Gunn et al, 1998; Gunn, 2001).
5. Interaction of Salmonella with the complement
system
5.1 Complement as an antimicrobial defence system
The complement system of serum is a key component of the innate immunity
defence against bacterial infections and bridges the innate and adaptive
immunity (Rautemaa and Meri, 1999). It consists of a group of protein
components that circulate in blood and other body fluids mainly as inactive
zymogens and whose activation cascade is initiated by the formation of the
antibody-antigen complexes at the infection sites (classical pathway), by direct
recognition of the foreign material such as bacterial cells (alternative pathway)
or by binding of the mannose-binding lectin to mannose structures on the
bacterial surfaces (lectin pathway) (Walport et al 2001a; 2001b). Activation of
the complement cascade has many biological consequences. After activation,
complement components induce the migration of phagocytes into the infection
site, enhance the receptor-mediated phagocytosis by opsonizing microbes and
lyse the bacterial cells by inserting the membrane attack complex (MAC) on the
bacterial surfaces (Table 1).
The complement cascade is tightly regulated to prevent unnecessary
consumption of the complement components and to confine the functions of the
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complement within the infection site. The activation of any of the three
complement pathways leads to the cleavage of the complement component C3
into C3b that efficiently activates the complement cascade. The amount of C3 in
serum is high (1.25 mg/ml) and therefore, the amount of C3b is easily increased
during bacterial infections. To prevent undesired activation of the complement
cascade, C3b is regulated in plasma by factor H (fH) and factor I (fI) that block
the formation of C3b from C3 and enzymatically degrade C3b.
Table 1. Functions of the selected complement components. Many of the complement
components are synthesized as inactive proenzymes and are proteolytically converted to the
fragments that either bind to the bacterial surface or are released into the microenvironment.
Complement protein Function
C3 Precursor of C3a and C3b
C3a Anaphylatoxin: increases vascular permeability
C3b Opsonin; component of the C3-convertase of the
alternative pathway; component of C5-convertase of all
pathways
C4 Precursor of C4a and C4b
C4a Anaphylatoxin
C4b Opsonin; component of the C3-convertases of the classical
and lectin pathways
C5 Precursor of C5a and C5b
C5a Anaphylatoxin; chemotaxin: induces the migration of the
phagocytes into the infection site
C5b Initiator of the MAC formation
C5bC6C7C8C9 MAC complex
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5.2 Resistance mechanisms of Salmonella against the complement
system
In general, complement is cytolytic against Gram-negative bacteria. Many
pathogens have developed mechanisms to evade complement attack and killing.
S. enterica sv Typhi protects itself against complement attack with the Vi
polysaccharide capsule (Looney and Steiqbiqel, 1986). The uncapsulated
Typhimurium, on the other hand, is protected by long heterogenic O-antigen side
chains of  the smooth LPS.  Smooth LPS is  the major  determinant  of  the serum
resistance in Salmonella and mutants with an incomplete LPS are more easily
lysed by the MAC (Grossman et al, 1987; Murray et al, 2003; Rautemaa and
Meri, 1999).
Three outer membrane proteins of Salmonella,  TraT,  Rck and PagC, have also
been shown to protect Salmonella against complement. TraT is a surface protein
of E. coli and Typhimurium. In E. coli, traT resides in the F-like plasmid and the
function of TraT is to prevent the conjugational transfer of DNA and formation
of mating pairs between F+-cells (Rhen and Sukupolvi, 1988). TraT also protects
E. coli against complement-mediated killing and phagocytosis by M?s (Moll et
al, 1980; Agüero et al, 1984). In Typhimurium, TraT is encoded by the 94-kb
virulence plasmid (Rychlik et al, 2006) and it increases the serum resistance by
inhibiting the insertion of MAC on the bacterial surface (Rhen and Sukupolvi,
1988; Pramoonjago et al, 1992). Rhen and Sukupolvi (1988) suggested that TraT
may also have a role in survival of Salmonella inside M?s.
Rck is a 17-kDa outer membrane protein of Typhimurium. It is also encoded by
the 94-kb virulence plasmid (Rychlik et al, 2006), and overexpressed Rck
protects rough Salmonella and E. coli against complement (Heffernan et al,
1992a). The serum-resistance mechanism of Rck is that it inhibits the proper
MAC  insertion  on  the  bacterial  surface  and  releases  the  complex  from  the
bacterial cell (Heffernan et al, 1992a). Based on the predicted amino acid
sequence, Rck belongs to the homologous family of outer membrane proteins of
Enterobacteriaceae. Other members of this family are Ail of Y. enterocolitica
that also mediates the bacterial serum resistance, OmpX of Enterobacter cloacae
and Lom of E. coli that have not been found to be involved in the virulence, and
PagC of S. enterica (Heffernan et al, 1992b; Cirillo et al, 1996). In
Typhimurium, pagC is a PhoP/Q regulated gene and required for the intra-M?
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survival and the full virulence of Typhimurium in mice (Miller et al, 1989).
PagC has also been shown to protect S. enterica sv  Choleraesuis  against  the
complement-mediated killing by a so-far uncharacterized mechanism (Nishio et
al, 2005).
6. Bacterial interference with the host extracellular
matrix and matrix-degrading proteolytic systems
6.1 Interaction of Salmonella with the host extracellular matrix
Adhesiveness to tissues is an important virulence factor of bacterial pathogens
(Pizarro-Cerda and Cossart, 2006; Westerlund and Korhonen, 1993). Salmonella
expresses nonfimbrial and fimbrial adhesins that bind to ECM and BM
components, mainly to fibronectin and laminin. The outer membrane proteins
Rck and PagC, which also have a role in resistance of Salmonella against
complement, bind to laminin and to reconstituted BM, and Rck also binds to
fibronectin (Crago and Koronakis, 1999). ShdA is a large surface protein that
binds fibronectin (Kingsley et al, 2002) and seems to be important for the
colonization of the murine cecum by Typhimurium (Kingsley et al, 2003). MisL
binds to type IV collagen and fibronectin (Dorsey et al, 2005). Expression of
MisL was shown to mediate bacterial invasion into human colonic carcinoma
cell line T84 and colonization of mouse intestine (Dorsey et al, 2005).
From fimbrial adhesins, type 1 fimbriae mediate binding of Salmonella to high-
mannose chains in laminin (Kukkonen et al, 1993) and the thin aggregative
fimbriae (curli) to fibronectin (Collinson et al, 1993). Type 1 fimbriae and curli
of Salmonella also bind Plg on the bacterial surface (Sjöbring et al, 1994;
Kukkonen et al, 1998), and curli also binds tPA (Sjöbring et al, 1994). Cell-
bound Plg is then effectively activated to plasmin by host tPA. tPA-activated
plasmin on Salmonella surface degrades laminin and ECM and enhances
penetration of Salmonella through the reconstituted BM (Lähteenmäki et al,
1995). Bound plasmin is protected from ?2AP because the binding of plasmin to
bacterial cell and to ?2AP involve the same lysine-binding structures in the
plasmin molecule (Coughlin, 2005). As described above, PgtE activates Plg in
vitro (Sodeinde and Goguen, 1989), and Salmonella thus has both direct and
indirect mechanisms to generate active plasmin. Taken together, the binding to
ECM and BM components and plasmin-mediated degradation of ECM and BM
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may assist Salmonella to  invade  through  tissue  barriers  and  to  colonize  the
infection sites.
6.2 Matrix metalloproteinases in bacterial infections
The MMPs are a family of 25 zinc-dependent endopeptidases targeting the ECM
components. They have a role in cell migration, tissue remodelling and
modulation of inflammation and innate immunity (Parks et al, 2004; Sternlicht
and Werb, 2001). Different MMPs have overlapping proteolytic affinities and,
collectively, cause degradation of the ECM components (Sternlicht and Werb,
2001). Based on the substrate specifities, MMPs are divided into collagenases,
gelatinases, stromelysins and elastases. Additionally, MMPs include membrane-
type MMPs that are surface-anchored. In addition to ECM components,
substrates of MMPs include other proteinases, proteinase inhibitors, cytokines
and chemokines (McCawley and Matrisian, 2001).
The  MMPs  are  secreted  as  inactive  proenzymes  by  various  cell  types,  e.g.,  by
monocytes, M?s and DCs (Harper et al, 1971; Sternlicht and Werb, 2001). The
MMPs are homologous in their overall structure (Fig 2) and have a zinc-binding
catalytic domain, an N-terminal pre-domain with a signal sequence and a pro-
domain with a conserved cysteine (Cys) that chelates the catalytic Zn2+-ion and
keeps the enzyme in a pro-enzyme form (Stöcker et al, 1995). Most MMPs also
contain a C-terminal hemopexin/vitronectin-like domain that binds substrates
and tissue inhibitors of MMPs and is involved in activation of some MMPs
(Sternlicht and Werb, 2001). Various molecules, such as other MMPs, plasmin
and trypsin, are able to disrupt the Cys-Zn2+ binding that maintains the latent
form of proMMP. This leads to an intermediate activation of MMPs. Another
cleavage, which can be autocatalytic, is needed to fully activate the enzyme
(Johansson et al, 2000; Woessner and Nagase, 2002). Some MMPs also have
additional binding sites and, for example, MMP-9 has collagen/gelatin binding
domains (Allan et al, 1995; Woessner and Nagase, 2002).
The gelatinases,  MMP-9 (92 kDa gelatinase;  gelatinase B) (Fig 2)  and MMP-2
(72 kDa-gelatinase; gelatinase A), have a role in many physiological and
pathological conditions and their role in cancer biology has been intensively
studied. MMP-9 and MMP-2 are expressed by various cell types, such as
monocytes and M?s (Johansson et al, 2000; Mohan et al, 1998; Munaut et al,
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1999). Gelatinases degrade a variety of ECM proteins; i.e. type IV collagen that
is  a  central  component  in  BMs,  type V,  VII,  X,  XI and XIV collagens,  gelatin
(denaturated collagen), elastin, proteoglycan core proteins and fibronectin
(Johansson et al, 2000). MMP-2 also degrades native type I collagen (Aimes and
Quigley, 1995) suggesting that it has a role in the remodelling of collagenous
ECM. However, more important in the initial degradation of ECM collagens are
the collagenases (MMP-1, -8 and -13) that cleave fibrillar collagens to fragments
that are rapidly denaturated to gelatin at the body temperature and thereby
become susceptible to the degradation by gelatinases (Billinghurst et al, 1997;
Johansson et al, 1997).
Figure 2. Domain structure of proMMP-9. Pre; N-terminal signal sequence, Pro; propeptide
with a conserved Cys residue, Catalytic; catalytic domain includes the collagen binding domains
(II)  and  the  Zn2+-binding site (Zn). Hemopexin; four C-terminal hemopexin/vitronectin-like
domains, the first and last of which are linked by a disulfide bond. The catalytic domain is linked
to the hemopexin domain by a hinge region.
Most MMPs are not constitutively expressed by cells in vivo, but their
expression is induced by exogenous signals such as contact with ECM or
microbial surface components (Johansson et al, 2000; Opdenakker et al, 2001).
Both bacterial and viral infections have been shown to induce production of
MMPs from host  cells  such as  monocytes  and M?s (Elkington et al, 2005). A
limited number of bacteria, Pseudomonas aeruginosa, Vibrio cholerae,
Porphyromonas gingivalis, Treponema denticola, pneumococci and group A
streptococci have been shown to produce proteolytic enzymes that activate host
proMMPs (Oggioni et al, 2003; Okamoto et al, 1997; Pattamapun et al, 2003;
Sorsa et al, 1992; Tamura et al, 2004). Some bacterial species have also been
shown to express collagenases and gelatinases (Harrington, 1996; Potempa et al,
2000; Watanabe, 2004). LPS from Salmonella and other enteric bacteria induces
secretion of proMMP-9 in M?s (Xie et al,  1994).  No  reports  of Salmonella-
mediated activation of proMMPs have been published; however, mice deficient
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in MMP-9 are more resistant to Typhimurium-induced enterocolitis than wild-
type mice (Castaneda et al, 2005) and MMP-3 deficient mice are more resistant
to systemic Typhimurium infection than wild-type mice (Handley and Miller,
2007). These results suggest a role for MMPs in Salmonella infections.
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7. Aims of the study
When this study was initiated, it was already known that PgtE of S. enterica is a
Plg activator. However, the activation was only seen with recombinant bacteria
and remained cryptic in isolates of Salmonella grown in laboratory culture media
(Sodeinde and Goguen, 1989; Lähteenmäki et al, 1995). On the other hand, Pla
of Y. pestis was known to be a multifunctional Plg activator and OmpT of E. coli
was known to require LPS to be proteolytically active. It was also known that
during growth of Salmonella inside SCV of M?, pgtE is upregulated and several
genes involved in LPS synthesis are downregulated (Eriksson et al, 2003). This
PhD work aimed to address the role of PgtE activity in S. enterica pathogenesis.
In particular, important goals in this study were
-to assess the conditions where PgtE is active
-to study how LPS effects the activity of PgtE
-to compare the proteolytic and nonproteolytic functions of Pla and PgtE
-to identify biologically important substrates for PgtE
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8. Materials and methods
Table 2. Bacterial strains and cultured eukaryotic cell line used in this study.
Bacterial strains Relevant characteristics Article Reference
E. coli
XL1-Blue MRF´ Rough LPS I, II, III, IV Stratagene
IHE3070 Rough LPS I Selander et al, 1986
IHE3074 Rough LPS I Selander et al, 1986
IHE3034 O18 LPS I Selander et al, 1986
IHE1049 O1 LPS I Pere et al, 1988
M15 I, IV Qiagen
BL21 ?DE F- hsd ompT lon I Novagen
S. enterica sv
Typhimurium
SL1102 Re LPS I Wilkinson et al, 1972
SL1102-1 ?pgtE derivative of SL1102 I This study
14028 Smooth LPS I, II, IV ATCC
14028-1 ?pgtE derivative of 14028 I, II, IV This study
14028R Rough LPS derivative of 14028 II, III, IV Wick et al, 1994
14028R-1 ?pgtE derivative of 14028R II, III, IV This study
SH401 Rough LPS I Kukkonen et al, 1993
SL696 Smooth LPS I Wilkinson et al, 1972
SL901 Semirough LPS I Wilkinson et al, 1972
Minnesota
SF1112 Ra LPS I Schmidt and Lüderitz, 1969
SF1127 Rb1 LPS I Schmidt and Lüderitz, 1969
SF1119 Rc LPS I Schmidt and Lüderitz, 1969
SF1121 Rd1 LPS I Schmidt and Lüderitz, 1969
SF1118 Rd2 LPS I Schmidt and Lüderitz, 1969
SF1167 Re LPS I Schmidt and Lüderitz, 1969
Y. pseudotuberculosis
Pa3606 01b LPS, pYV- I Tsubokura and Aleksic, 1995
PB1 01b LPS, pYV- I Perry and Brubaker, 1983
PB1?wb Lacks O-antigen
due to??wb, pYV- I Obtained from J.A. Bengoechea
Eukaryotic cell lines
J774A.1 Murine M?-like cell line II, IV ATCC (TIB-67)
ECV-304 Endothelial-like cell line I ATCC (CRL-1998)
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Table 3. Plasmids used and constructed in this study.
Plasmid Relevant characteristics Article Reference
pSE380 trc promoter, lacO operator, lacI I, II, III, IV Invitrogen
pMRK3 pgtE in pSE380 I, II, III, IV This study
pMRK31 PgtE D206A I, II, III, IV This study
pMRK32 PgtE R138E I This study
pMRK33 PgtE R171E I This study
pMRK34 PgtE R138E R171E I This study
pMRK1 pla in pSE380 I, IV Kukkonen et al, 2001
pMRK2 ompT in pSE380 I Kukkonen et al, 2001
pQE30 T5 promoter, lac operator, His6-tag I, IV Qiagen
pREP4 lacI I, IV Qiagen
pla/ pgtE-hybrids in pSE380
pMRK11 Pla with PgtE 1-40 IV This study
pMRK12 Pla with PgtE 52-130 IV This study
pMRK13 Pla with PgtE 143-189 IV This study
pMRK14 Pla with PgtE 190-230 IV This study
pMRK15 Pla with PgtE 235-292 IV This study
pMRK1.32 Pla 161KGVRVIGYN?161HGVRGIGYS IV This study
pMRK1.41 Pla 212D?212K IV This study
pMRK1.51 Pla 259TIDKN?259IIDKT IV This study
pMRK1.52 Pla 267SVSI?267TAYF IV This study
pMRK1.53 Pla 278SNK?278ANN IV This study
pla/ pgtE-hybrids in pMRK11 (all contain PgtE 1-40)
pMRK1122 Pla 89NENQSE?89SSEQPG IV This study
pMRK1123 Pla 98HSS?98RSI IV This study
pMRK1131 Pla 149SYNNGAYT?149IYDNGRYI IV This study
pMRK1132 Pla 161KGVRVIGYN?161HGVRGIGYS IV This study
pMRK113 Pla 149SYNNGAYT?149IYDNGRYI and
Pla 161KGVRVIGYN?161HGVRGIGYS IV This study
pMRK1141 Pla 212D?212K IV This study
pMRK1151 Pla 259 TIDKN?259IIDKT IV This study
pMRK1152 Pla 267SVSI?267TAYF IV This study
pMRK1153 Pla 278SNK?278ANN IV This study
pMRK115 Pla 259TIDKN?259IIDKT and
Pla 267SVSI?267TAYF and
Pla 278SNK?278ANN IV This study
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Table 4. Methods used in this study.
Method Described and / or used in
Cultivation of S. enterica I, II, III, IV
Induction of PgtE expression under the PhoP/Q inducing conditions I, II, III, IV
Induction of omptin production in recombinant bacteria I, II, III, IV
Cultivation of eukaryotic cells I, II, IV
Allelic replacements I, II
Generation of point mutations I
Generation of pla/pgtE hybrid constructs IV
DNA sequencing I, IV
Western blotting to characterize the omptin expression I, II, IV
Expression of the recombinant His6-tagged omptin in E. coli I, IV
Purification and reactivation of the His6-tagged omptin I, IV
Plg cleavage and activation I, II, IV
Adhesion to Matrigel I
Invasion into eukaryotic cells I
?2AP cleavage and inactivation II
Laminin degradation II
Infection of J774A.1 M?-like cells with the phagocytosis assay II, IV
Preparing of J774A.1 cell lysates II, IV
Isolation of SCVs from J774A.1 cells II, IV
Silver staining II
Complement protein cleavage III
Serum sensitivity assays III
Degradation of gelatin IV
Activation of proMMP-9 IV
Gelatin zymography IV
Mouse infection experiments IV
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9. Results and discussion
9.1 Role of lipopolysaccharide for the activity of PgtE of Salmonella
enterica and Pla of Yersinia pestis (I, II, IV)
Virulent S. enterica isolates normally have smooth LPS, and although these
bacteria have an intact pgtE gene, they do not express PgtE activity (Sodeinde
and Goguen, 1989; Lähteenmäki et al, 1995). However, PgtE was active when
overexpressed in recombinant E. coli K-12 (Sodeinde and Goguen, 1989) which
has a rough, Rc type of LPS (Holst, 2000). To assess the effect of the O-antigen
on PgtE functions we first studied Plg activation by the smooth, widely used
virulent strain S. enterica sv Typhimurium 14028 and two rough Salmonella
strains, SL1102 and 14028R. Bacteria were cultivated in the presence of
PhoP/Q-inducing N-minimal medium, which mimics the intracellular conditions
of  SCV  and  has  a  low  Mg2+ concentration. The growth in the N-minimal
medium was found to induce the expression of PgtE in all strains (Fig 1B in I;
Fig 4 in II). The rough SL1102 and 14028R efficiently activated Plg, whereas
the smooth 14028 only poorly promoted formation of plasmin (Fig 1A in I; Fig
3). S. enterica 14028R, which is an isogenic derivative of 14028, was more
powerful  in  Plg  activation  than  SL1102  (Fig  3).  As  rough  LPS  seemed  to  be
critical for PgtE activity we studied the effect of O-antigen length on PgtE
functions. PgtE-encoding pMRK3 was expressed in a series of S. enterica
isolates, which express LPS molecules of different length and were tested for Plg
activation. The strains with a rough LPS (chemotypes Ra, Rb1, Rc, Rd1, Rd2, Re)
were  efficient,  whereas  the  strain  with  smooth  LPS  was  poor  in  Plg  activation
(Fig 1C in I). Plg activation by the strain with a semirough LPS (LPS contains
only one O-antigen unit) was slightly decreased as compared to the rough strains
(Fig 1C in I). Further, Plg activation was seen in rough but not in smooth
recombinant E. coli transformed with pMRK3 (Fig 4 in I).
To confirm that PgtE has a role in Plg activation by S. enterica, we constructed a
site-specific deletion of pgtE in 14028, SL1102 and 14028R. The resulting pgtE-
deficient derivatives 14028-1, SL1102-1 and 14028R-1 were negative in Plg
activation (Fig 1A in I; Fig 3). Complementation of the pgtE-negative SL1102-1
and 14028R-1 with the PgtE-encoding pMRK3 restored Plg activator activity
(Fig  1A  in  I;  Fig  3).  A  low  Plg  activator  activity  was  also  seen  with  14028-
1(pMRK3) (Fig 1A in I), which overexpressed pgtE. The expression levels of
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PgtE were similar in the complemented recombinant derivatives used in the
assays (Fig 1B and 1D in I).
Figure 3. Plg activation by smooth and rough S. enterica. Plg activation was measured by
incubating bacteria and human Plg with the chromogenic plasmin substrate. The strains used in
this assay were (A) the smooth pgtE-proficient S. enterica 14028 and the rough pgtE-proficient S.
enterica 14028R and SL1102 and (B) S. enterica 14028R, 14028, pgtE-negative 14028R-1 and
14028-1, the PgtE-expressing 14028R-1(pMRK3) and 14028R-1(pSE380) with the vector
plasmid. The means of duplicate samples in a representative assay are shown.
We found that Pla of Y. pestis also is active only in bacterial strains with rough
LPS. The Pla-encoding pMRK1 was transformed into the temperature-sensitive
Yersinia pseudotuberculosis strains Pa3606 and PB1 and into the rough ?wb
derivative of PB1. Plg activation was tested at 25°C and 37°C, which are the
temperatures where Y. pseudotuberculosis Pa3606 and PB1 express smooth and
rough LPS, respectively (Bengoechea et al, 1998). Pa3606(pMRK1) and
PB1(pMRK1) were efficient in Plg activation after cultivation at 37°C. No Plg
activation  was  detected  with  cells  from  25°C  (Fig  2A,  2B  and  2C  in  I).  The
rough strain PB1?wb(pMRK1) activated Plg after  growth at  both temperatures
(Fig 2C in I). The LPS types in these strains were confirmed by silver staining
and electrophoresis (data not shown). Similarly, Pla activity was detected in
rough but not in smooth recombinant E. coli (Fig 4 in I). The requirement of the
LPS on Pla and PgtE activity was also shown with the purified proteins (Fig 2D
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in I; Fig 4). As previously noted for the purified OmpT of E. coli (Kramer et al,
2000; 2002), His6-Pla and His6-PgtE that were purified under denaturizing
conditions were enzymatically active after reconstitution with rough LPS and
inactive when reconstituted in the absence of LPS or in the presence of smooth
LPS (Fig 2D in I; Fig 4).
Figure 4. Plg activation by purified PgtE. Plg
activation by purified His6-PgtE in the presence
of rough, Rc type of LPS or in the absence of
LPS. Plg activation by LPS alone is also
shown. Plg activation was measured by
incubating the purified PgtE and human Plg
with the chromogenic plasmin substrate. The
means of triplicate samples are shown.
A consensus LPS-binding motif of four basic amino acids has been identified in
prokaryotic and eukaryotic LPS-binding proteins. This LPS-binding motif is
partially present in the OmpT sequence, and two amino acids, Arg138 and
Arg171, of the LPS-binding motif are present in PgtE and Pla in the correct
spatial organization to form electrostatic and hydrogen bonds with 4’ phosphate
in lipid A (Ferguson et al, 2000; Vandeputte-Rutten et al, 2001; Kramer et al,
2002; Fig 1). To study the role of Arg138 and Arg171 in PgtE functions, we
substituted the arginines for glutamates separately (in plasmids pMRK32 and
pMRK33) and together (pMRK34). Salmonella SL1102-1 was complemented
with each of the three plasmids and tested for Plg activation. The derivatives
with the substitutions PgtE R138E and PgtE R171E were as efficient in Plg
activation as SL1102-1(pMRK3) complemented with pgtE, whereas no
activation was seen with the derivative harbouring the substitutions PgtE R138E
R171E (Fig 3A in I).
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Pla is an invasin and an adhesin (Lähteenmäki et al, 1998; 2001b) and we
studied whether PgtE also is active in these functions. Both Pla-encoding
pMRK1 and PgtE-encoding pMRK3 enhanced adhesion of rough recombinant
E. coli isolates onto the ECM secreted by the ECV-304 cells (Fig 4 in I). Pla also
mediated the invasion of rough E. coli strains into the ECV-304 cells whereas
PgtE was negative in this function (Fig 4 in I). These results indicate that PgtE is
an adhesin but not an invasin. The smooth Pla- and PgtE-expressing E. coli
isolates  were  negative  in  both  invasion  and  adhesion  (Fig  4  of  I),  which  is  in
agreement with the O-antigen masking functions of Pla and PgtE. Adhesion of
Pla does not depend on the proteolytic activity as the protease-negative Pla is
almost as adhesive to the ECM secreted by the ECV-304 cells as the wild-type
Pla (Lähteenmäki et al, 2001b). It remains open whether also the PgtE-mediated
adhesion is independent of the proteolytic activity. Plg activation further
confirmed that only E. coli isolates with rough LPS expressed functions of either
PgtE or Pla (Fig 4 in I). Our results also confirm that OmpT-expressing bacteria
are poor in invasion, adhesion and Plg activation (Fig 4 in I; Lähteenmäki et al,
1998; 2001b).
These results indicate that PgtE and Pla have a dual interaction with LPS. They
require  rough  LPS  to  be  functional  but  are  sterically  inhibited  by  the  long  O-
antigen side chains of LPS. Similarly, the O-antigen has been shown to interfere
with the function of Y. pseudotuberculosis invasin-protein when expressed in
Shigella flexneri (Voorhis et al, 1991). Y. pestis has evolved from Y.
pseudotuberculosis O1b and has a rough LPS due to inactivation of five genes in
the gene clusters encoding the LPS biosynthetic pathway (Achtman et al, 1999;
Skurnik et al, 2000). This far, the advantage of the rough LPS for Y. pestis has
remained unknown (Skurnik et al, 2000; Parkhill et al, 2001). Our results
indicate that the lack of O-antigen allows efficient Pla-mediated proteolysis,
invasion and adhesion of Y. pestis, and our hypothesis is that this is the main
advantage for the rough LPS in Y. pestis. In virulent S. enterica isolates, on the
other hand, activity of PgtE is sterically inhibited by the long O-antigen and is
only seen in rough derivatives of Salmonella when cultivated in vitro (I, II, IV).
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9.2 Activity of PgtE in Salmonella released from macrophages (II, IV)
Transcription of pgtE is under the control by the PhoP/Q system and upregulated
in mouse M?s. Therefore, we studied the effect of intracellular conditions on
PgtE functions by infecting murine J774A.1 M?-like cells with Salmonella
14028 and the pgtE-negative mutant 14028-1. The M?s  were  lysed  after  20
hours of infection and tested for ?2AP degradation. ?2AP was chosen here as a
model substrate for PgtE-mediated proteolysis after our finding that 14028R, but
not 14028R-1, cleaved and inactivated this biologically important antiprotease
after growth in the PhoP/Q inducing conditions (Fig 1A and 1B in II; see 9.5.1).
For comparison, Salmonella 14028 was cultivated in vitro in the PhoP/Q
inducing N-minimal medium as well as in Luria broth. When bacteria were
grown in the laboratory media, the PgtE activity in 14028R was significantly
higher than in 14028 (Fig 1 and 4 in II), which is compatible with the
interference of PgtE functions by the O-antigen discussed above. Notably, the
lysate from M?s infected with Salmonella 14208 was far more efficient in ?2AP
degradation than 14028 from Luria broth or from N-minimal medium (Fig 3 in
II). The lysates from J774A.1 cells infected with the pgtE-negative mutant
14028-1 and from uninfected J774A.1 cells were inactive in ?2AP degradation
(Fig 3 in II), indicating that PgtE was needed for the antiprotease cleavage. We
also isolated SCVs from 14028- and 14028R-infected J774A.1 cells to decrease
the amount of J774A.1 cell material contaminating the test samples. Bacteria
from SCVs were active in ?2AP degradation, with 14028 and 14028R showing
similar activity (Fig 4 in II). Likewise, Salmonella 14028 from M?s efficiently
degraded also another  polypeptide substrate,  gelatin (Fig 3A and 3B in IV; see
chapter 9.5.3), which indicates that the enhancement of the proteolytic activity
of PgtE in M?s is not associated with the antiprotease substrate but rather is a
general phenomenon.
To study whether the increased proteolytic activity of Salmonella 14028 from
the infected M?s results from the increased production of PgtE, or from the
modification of the O-antigen of LPS, or both, we analyzed the bacteria from
SCVs by Western blotting with anti-PgtE antibodies and by silver staining for
detection of LPS. PgtE expression was high in both 14028 and 14028R from
SCVs compared to bacteria grown in Luria broth (Fig 4 in II). PgtE expression
was also increased in N-minimal medium but was not as high as in bacteria from
SCVs (Fig 4 in II). Further, silver staining revealed that O-antigen length was
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reduced during growth of Salmonella 14028 inside M?s as compared to 14028
grown in Luria broth (Fig 4 in II). Growth of 14028 in N-minimal medium
promoted only a slight modification in the LPS carbohydrate chain pattern (Fig 4
in II).
Our results indicate that the PgtE expression is upregulated and the O-antigen
synthesis downregulated during the growth of Salmonella within  M?. These
results are in accordance with the data showing increased transcription of 14028
pgtE in J774A.1 M?-like cells (Eriksson et al, 2003) and the role of the PhoP/Q
system in pgtE expression (Guina et al, 2000; Bader et al, 2003). Our results
also show that both the increased PgtE-expression level and the reduced O-
antigen length are important for proteolytic activity of PgtE and that PgtE is
fully active after the growth of Salmonella within M?.  As  it  is  thought  that
Salmonella is  continuously  released  from  M?s to spread into new ones
(Sheppard et al, 2003; Sheppard and Mastroeni, 2004), we suggest that PgtE is
functional during these transient extracellular growth phases and thus can
facilitate bacterial dissemination from one M? to another.
9.3 Role  of  PgtE  in  survival  of Salmonella inside macrophages in vitro
(II)
In vitro, PgtE degrades CAMPs and promotes resistance of Salmonella against
CAMP-mediated killing (Guina et al, 2000), which led us to evaluate the
possible role of PgtE in survival of Salmonella within M?s. During the 20-hour
infection of murine J774A.1 M?s, the pgtE-proficient Salmonella 14028 cells
multiplied to approximately 170 % of internalized bacteria. On the contrary, the
number of pgtE-negative 14028-1 cells reduced to approximately 50 % (II; Fig
5), suggesting that PgtE promotes the intracellular survival of Typhimurium
inside murine M?s. It remains open whether the increased survival observed in
this study results from the previously reported degradation of CAMPs by PgtE
(Guina et al, 2000) or whether additional factors are involved. Typhimurium is
known to survive better in murine M?s than in human M?s (Schwan et al,
2000), and PgtE was found not to have a role in survival of Typhimurium 14028
within human primary M?s and DCs (Pietilä et al, 2005). This may indicate that
PgtE degrades CAMPs of murine M?s, but not those of human M?s.  It  may
also be that the major targets of PgtE are not intracellular but extracellular (see
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chapter 9.5) and that PgtE is more important after release of Salmonella from the
host cell.
Figure  5.  Effect  of  PgtE  on  survival  of
Salmonella inside murine M?s. J774A.1 cells
were infected with Salmonella 14028 and the pgtE-
negative derivative 14028-1. After a 20-hour
incubation, J774A.1 cells were lysed and the
amount of bacteria were calculated by viable
counting relative to the bacterial amount at time
point 0 hour. The means and ranges from triplicate
wells of a representative assay are shown.
9.4 Effect of PgtE on survival of Salmonella in mice (IV)
To study whether PgtE has a role in virulence of Salmonella in vivo we infected
BALB/c mice intraperitoneally with Salmonella 14028 or 14028-1. After one or
three days of infection, bacterial loads in the livers and spleens were determined
by viable counting of homogenized organs. One day post infection, the amount
of Salmonella 14028 was nearly ten times higher than the number of 14028-1
both in the liver  and in the spleen (Fig 4 in IV).  Three days post  infection the
difference between 14028 and 14028-1 was not as high and the amount of
bacteria had increased at the same rate, even if Salmonella 14028-1 still
remained at  a  lower level  than 14028 (Fig 4 in IV).  These results  indicate  that
PgtE has a role in survival of Salmonella within the murine host in vivo, and
suggest that it can be important during early stages of infection when Salmonella
is migrating into the host organs.
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9.5 Identification of novel substrates for PgtE
9.5.1 Alpha2-antiplasmin (II)
As shown above (see chapter 9.2), we found that the rough S. enterica 14028R
cleaved ?2AP when grown to produce PgtE. Cleavage of the 70 kDa ?2AP to a
approximately 50 kDa cleavage product was detected with the rough 14028R but
not with the pgtE-negative derivative 14028R-1 (Fig 1A in II). Complementation
of 14028R-1 with pgtE in trans with the plasmid (pMRK3) restored the ability
of 14028R-1(pMRK3) to degrade ?2AP (Fig 1A in II). Similarly to Salmonella
14028R and 14028R-1(pMRK3), E. coli XL1(pMRK3) cleaved ?2AP into a 50
kDa cleavage product  (Fig 2A in II).  These results  confirm the role  of  PgtE in
?2AP degradation. The catalytic residue Asp206 (Vandeputte-Rutten et al, 2001)
is conserved in the omptin proteins and needed for Plg activation by Pla
(Kukkonen et al, 2001). We substituted Asp206 with alanine in plasmid
pMRK31 and observed that the derivative 14028R-1(pMRK31) failed to degrade
?2AP  (Fig  1A  in  II),  which  indicates  that  the  proteolytic  activity  of  PgtE  is
important for ?2AP degradation.
To test whether PgtE-mediated degradation of ?2AP also leads to inactivation of
the protease inhibitor, we incubated bacteria first with ?2AP and then with
plasmin. The residual inhibitory ?2AP activity was estimated by measuring
plasmin activity. ?2AP incubated with PgtE-expressing Salmonella 14028R,
14018R-1(pMRK3), and E. coli XL1(pMRK3) failed to inhibit plasmin activity,
whereas after incubation with 14028R-1 and 14028R-1(pMRK31), ?2AP still
efficiently inhibited plasmin activity (Fig 1B and 2B in II). This indicates that
PgtE inactivates the protease inhibitor ?2AP.
We next studied the effect of PgtE-mediated Plg activation and ?2AP
inactivation on degradation of laminin. Laminin is an important component of
ECM and a well-characterized substrate of plasmin (Salonen et al, 1984) and
incubation of XL1(pMRK3) with Plg on immobilized, 125I-labelled laminin
promoted  release  of  radioactivity  from  laminin  (Fig  2C  in  II).  Only  a  small
release of radioactivity was detected with XL1(pSE380) harbouring the vector
plasmid. Addition of ?2AP only slightly reduced the laminin degradation
mediated by suspensions of XL1(pMRK3) and Plg, whereas laminin degradation
with plasmin alone was efficiently inhibited when ?2AP was added (Fig 2C in
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II). The result shows that PgtE potentiates plasmin-mediated degradation of a
biologically important substrate, laminin, in the presence of an important
antiprotease.
The importance of the ?2AP degradation in the interference with the host Plg
system was further indicated with the lysates of Salmonella-infected J774A.1
M?-like cells. M?s activate Plg to plasmin by an uPA-dependent mechanism
(Vassalli et al, 1992) and lysates from both Salmonella-infected and uninfected
M?s converted Plg to plasmin (Fig 5 in II). Addition of ?2AP completely
inhibited the slow activation of Plg by the lysates from uninfected or 14028-1
infected cells (Fig 5 in II), but had only a limited effect on the rapid Plg
activation by the lysate from 14028-infected M?s (Fig 5 in II). It is noteworthy
that 14028R cleaved ?2AP nearly completely after being cultivated in N-
minimal medium, whereas degradation by 14028R from SCVs was only partial
(Fig 4 in II). A possible explanation for this is that during isolation of SCVs,
inhibitory  factors  from  the  M?s are enriched into SCV preparations and
therefore lower the ability of PgtE to cleave ?2AP. However, the lysates of
infected M?s were highly proteolytic (Fig 3 and 5 in II, Fig 3 in IV), suggesting
that the putative inhibitors of PgtE are absent or low in the lysates.
The Plg system and other proteolytic systems in the host are strictly regulated by
protease inhibitors that represent almost 10 % of the total protein mass of plasma
(Travis and Salvesen, 1983). A few invasive bacterial species including oral
pathogens, Y. pestis (Pla-mediated inactivation of ?2AP), Staphylococcus aureus
and Pseudomonas aeruginosa have been found to inactivate host antiproteases
(Carlsson et al, 1984; Potempa et al, 1986; Grenier, 1996; Kukkonen et al,
2001). The inactivation is thought to enhance uncontrolled proteolysis and to
promote the migration of these bacteria within the host. Our results indicate that
also PgtE of Salmonella proteolytically degrades and inactivates the antiprotease
?2AP. Both ?2AP inactivation and Plg activation interfere with the balance of
the host Plg system and may enhance the dissemination of Salmonella through
tissue barriers by plasmin-mediated degradation of ECM components. Compared
to Pla of Y. pestis PgtE is less effective in Plg activation (Fig 4 in I). As plasmin
converts prouPA into an active enzyme (Vassalli et al, 1992), Plg activation by
PgtE may be adequate to initiate the uPA-mediated plasmin formation on the
surface of M?s which secrete uPa and express uPA receptors (Vassalli et al,
1992). Therefore, the ability of PgtE to efficiently inactivate the plasmin
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inhibitor ?2AP may be more important than Plg activation itself for creating
uncontrolled plasmin proteolysis of tissue barriers during the Salmonella-
infection.
9.5.2 Complement components C3b, C4b and C5 (III)
Smooth Salmonella isolates are normally resistant against the complement
mediated killing due to presence of long O-antigen chains in the LPS (Joiner et
al, 1982; Grossman et al, 1987; Murray et al, 2003; 2005; 2006). However, as
shown in article II, the O-antigen length of Typhimurium is dramatically
reduced during the growth of Typhimurium within M?s. Therefore, we
reasoned that Salmonella requires other mechanisms to protect itself against the
complement. Pla of Y. pestis has been reported to cleave C3 (Sodeinde et al,
1992) and we studied whether also PgtE degrades the complement components
C3b, C4b and C5. These proteins belong to the group of ?2-macroglobulins
(Budd et al, 2004) and are crucial components of the complement cascade. The
PgtE-expressing S. enterica 14028R, 14028R-1(pMRK3) and E. coli
XL1(pMRK3) cleaved C3b, C4b and C5 into smaller degradation fragments (Fig
1 and 2 in III). XL1(pMRK3) also degraded intact C3 and C4 (data not shown).
The PgtE-mediated fragmentation of C3b was partly similar to the C3b cleavage
mediated by fI and fH, suggesting that the PgtE-mediated degradation of C3b
leads to its inactivation (Fig 1A in III). The pgtE-deficient 14028R-1, 14028R-
1(pSE380) and XL1(pSE380) as well as 14028R-1(pMRK31) and
XL1(pMRK31) expressing PgtE with a catalytic-residue substitution D206A
were inefficient in complement protein cleavage (Fig 1 and 2 in III). These
results indicate that complement protein cleavage is due to PgtE-mediated
proteolysis. Plasmin is known to degrade C3b (Seya et al, 1985), and Plg
activation by staphylokinase of S. aureus has  been  shown  to  lead  to  C3b
cleavage (Rooijakkers et al, 2005). We found that cleavage of C3b by 14028R
was increased in the presence of Plg (Fig 3 in III).
To study whether the PgtE-mediated cleavage of the complement components
has a role in the serum resistance of Salmonella, Salmonella 14028R and
14028R-1 were first cultivated in PhoP/Q-inducing conditions to activate PgtE-
expression and then incubated in the presence of 2% normal human serum
(NHS). The pgtE-proficient 14028R grew to higher numbers than did 14028R-1
(Fig 4A in III). On the other hand, in heat-inactivated serum both strains grew
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equally well and the amount of 14028R was 330% and amount of 14028R-1 was
370% higher than in the beginning of the incubation (data not shown). Taken
together, the results suggest a positive effect of PgtE on the bacterial serum
resistance. In accordance with the role of PgtE in the serum resistance, we
observed that after a 1-hour incubation, approximately 30% of Salmonella
14028R-1(pMRK3) cells survived in serum whereas 14028R-1(pSE380) was
almost totally killed (Fig 4B in III). Also E. coli XL1(pMRK3) was more
resistant to NHS than XL1(pSE380) (Fig 4C in III).
These results suggest that the PgtE-mediated proteolytic cleavage of the
complement components C3b, C4b and C5 promotes the serum resistance of
Salmonella. C3b cleavage was enhanced by the PgtE-mediated Plg activation,
further suggesting the importance of PgtE in the interference with the Plg
system. PgtE is not the only surface protein of Salmonella that has an impact on
bacterial survival in serum (Rhen and Sukupolvi, 1988; Heffernan et al, 1992a;
Nishio et al, 2005), but proteolytic degradation of complement components by
Salmonella has not been published earlier.
As expected, Salmonella 14028 and 14028-1 were highly serum resistant after
growth in Luria broth or in the PhoP/Q inducing conditions (data not shown). In
contrast, Luria-grown 14028R and 14028R-1 were killed in serum (data not
shown), which was expected as they lack complement resistance conferred by
the O-antigen chains and because cultivation of Salmonella in Luria broth does
not upregulate the PgtE expression. However, after growth in the PhoP/Q
inducing conditions both 14028R and 14028R-1 showed increased serum
resistance, suggesting that the simultaneous upregulation of PgtE and other
components protect rough Salmonella against complement-mediated killing (Fig
4  in  III).  Interestingly,  the  PhoP/Q  system  is  a  positive  regulator  in  the
transcription of pagC of Salmonella (Eriksson-Ygberg et al, 2006), and it is
possible that PagC acts together with PgtE against complement-mediated killing
after the bacteria are released from the M?s.
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9.5.3 Matrix metalloproteinase-9 and gelatin (IV)
The Plg system acts  together  with the MMPs to degrade the ECM components
and thus promotes eukaryotic cell migration (Sternlicht and Werb, 2001). M?s
use  the  Plg  system and  secrete  proMMPs  such  as  proMMP-9  to  enhance  their
migration through ECM (Myöhänen and Vaheri, 2004; Parks et al, 2004). Using
gelatin zymography (Snoek-van Beurden and Von den Hoff, 2005), we found
cleavage of proMMP-9 in assays where serum-free medium from human
primary M?s or purified human proMMP-9 were incubated with the PgtE-
expressing derivatives of Salmonella 14028R. Salmonella 14028R and 14028R-
1(pMRK3), but not 14028R-1, processed the 92 kDa proMMP-9 into smaller
fragments (Fig 1A in IV). Also E. coli XL1 transformed with pMRK3 cleaved
proMMP-9 (Fig 1C in IV). The cleavage products of proMMP-9 differed
slightly between the PgtE-expressing bacteria and trypsin (Fig 1A and 1C in IV).
The approximated sizes of the PgtE-generated cleavage products of proMMP-9
were  88  kDa,  82  kDa  and  74kDa  (Fig  1A  and  1C  in  IV).  Trypsin,  as  most
mammalian proteases, is known to process proMMP-9 first into a proteolytically
inactive intermediate form that is approximately 88 kDa in size. Activation of
the intermediate form results from further cleavage into fragments with sizes of
80 kDa, 74 kDa and 66 kDa (Woessner and Nagase, 2002; Snoek-van Beurden
and Von den Hoff, 2005).
The possible activation of proMMP-9 by PgtE was measured as cleavage of
fluorescein conjugated gelatin (DQ-gelatin). When DQ-gelatin was incubated in
the presence of proMMP-9 and S. enterica 14028R, 14028R-1(pMRK3) and E.
coli XL1(pMRK3), DQ-gelatin degradation was increased (Fig 1B and 1C in IV)
whereas no degradation of DQ-gelatin was detected with 14028R-1 (Fig 1B in
IV). This indicates that PgtE converts proMMP-9 into an active enzyme.
An interesting observation was that 14028R and 14028R-1(pMRK3) also
degraded DQ-gelatin in the absence of proMMP-9 (Fig 1B and 2A in IV). The
results suggest that PgtE both activates proMMP-9 to MMP-9 as well as directly
degrades gelatin. To assess this in more detail, Salmonella 14028R derivatives
were incubated with DQ-gelatin to study the kinetics of gelatin degradation and
with porcine skin gelatin to study the fragmentation pattern of gelatin by SDS
PAGE. Salmonella 14028R and 14028R-1(pMRK3) rapidly degraded both
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gelatin preparations whereas the pgtE-negative 14028R-1 was inactive in gelatin
degradation (Fig 2A and 2B in IV).
As shown above, Salmonella 14028 from mouse M?s expresses functional
PgtE. As a first step to assess whether the observed gelatin degradation is
biologically relevant, we probed the ability of Salmonella 14028 to degrade
gelatin once the cells were released from M?s. The Salmonella 14028-infected
M? lysate efficiently degraded both DQ-gelatin (Fig 3A in IV) and porcine skin
gelatin (Fig 3B in IV). The role of PgtE in gelatin degradation was confirmed
with Salmonella 14028 from the SCVs of infected J774A.1 M?s. The pgtE-
negative Typhimurium strain 14028-1 from the infected lysates and from the
SCVs was almost as inefficient in gelatin degradation as was the uninfected M?
lysate  (Fig  3A  and  3B  in  IV).  Taken  together,  these  results  show  that  the
Salmonella infection promotes the gelatinase activity in mouse M?s by a PgtE-
mediated fashion and that Salmonella also expresses a gelatinase on its surface
after release from mouse M?s. The M?s utilize the MMPs and the Plg system
in their migration and we suggest that during systemic salmonellosis PgtE is one
of the important components that induce the M?-mediated degradation of ECM
components and induces the migration of infected host cells.
PgtE differs  both structurally and in catalytic  mechanisms from MMPs as well
as from clostridial collagenases, which are the best-characterized groups of
gelatinases/collagenases. The MMPs and the clostridial collagenases are zinc-
dependent and secreted metalloproteinases with separate catalytic and substrate
binding domains (Woessner and Nagase, 2002; Wilson et al, 2003), whereas
PgtE  and  other  omptins  are  transmembrane  aspartate  proteases.  Despite  the
structural  differences,  PgtE  shares  some  functions  with  MMP-3  which  also
degrades gelatin, activates proMMP-9 and inactivates ?2AP (Ogata et al, 1992;
Lijnen et al, 2001; Sternlicht and Werb, 2001). Thus, we suggest that even if
PgtE is not structurally similar to collagenases it functionally mimics them.
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9.6 Structural basis for the substrate specificity of PgtE (IV)
The omptin family has spread through horizontal gene transfer, and Pla, PgtE
and the Erwinia omptin form a closely related subfamily (Kukkonen and
Korhonen, 2004). PgtE shares 72% amino acid sequence identity with Pla and
48% identity with OmpT of E. coli (Grodberg and Dunn, 1989; Sodeinde and
Goguen, 1989). Based on the sequence similarity and crystallized three-
dimensional structure of OmpT, the structures of PgtE and Pla were modelled
and  found  to  share  the  overall  structure  with  OmpT  (Kramer et al, 2000;
Kukkonen et al, 2001; Fig 1). Pla and PgtE are similar in structure and also, to a
degree, share putative virulence-associated functions. They activate Plg to
plasmin (Sodeinde and Goguen, 1989; I), inactivate ?2AP (Kukkonen et al,
2001; II), degrade complement components (Sodeinde et al, 1992; III) and
adhere onto BM (Lähteenmäki et al, 1998; 2001b; Fig 4 in I).
Using recombinant bacteria, we compared the ability of PgtE and Pla to activate
proMMP-9 and to degrade gelatin and found that Pla is inactive in these
functions (Fig 5A and 5B in IV). Interestingly, Pla, as well as PgtE carrying the
catalytic site substitution D206A cleaved proMMP-9 into an 88 kDa cleavage
product, but this cleavage did not lead to MMP-9 activity (Fig 1C, 5A and 5B in
IV).  This  suggests  that  both  PgtE  D206A  and  Pla  modify  proMMP-9  into  an
intermediate form, but do not produce enzymatically active MMP-9 (Woessner
and Nagase, 2002).
Transmembrane ?-barrel  proteins  such  as  omptins  are  very  stable  and  tolerate
large substitutions in their surface-exposed areas (Wimley et al, 2003). OmpT
was turned into a Pla-like protease by changing critical amino acids in the
surface-exposed loops (L1-L5, see Fig 1) between OmpT and Pla (Kukkonen et
al, 2001). To characterize the protein regions important for the gelatinolytic
activity in PgtE, we constructed Pla/PgtE hybrid proteins where each surface
loop of Pla was separately replaced by the corresponding loop of PgtE (Fig 6;
Fig 6A and 6B in IV). Analysis of gelatin degradation revealed that the
substitution of the N-terminal residues 1-40, which contains L1, significantly
increased gelatin degradation, whereas the constructs harbouring L2, L3 and L4
from PgtE were all negative and L5 marginally increased gelatin degradation
(Fig 6C in IV). The substitution analysis was continued by using the L1-hybrid
XL1(pMRK11) as a template. Derivatives XL1(pMRK1132), including L1 and
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the sequence 161HGVRGIGYS close to L3, XL1(pMRK1141) including L1 and
the non-identical amino acid 212K from L4 and XL1(pMRK1152) including L1
and 267TAYF close to L5 (Fig 6; Fig 6B in IV) significantly increased the
gelatinase activity when compared to L1 substitute on Pla (Fig 7A in III).
Simultaneous substitutions of the amino acids in L3 and L5 with L1 resulted in
efficient gelatin degradation, derivative XL1(pMRK115) with L1 and L5 was
even more effective than PgtE (Fig 7A in IV). The importance of L5 in gelatin
degradation was further demonstrated with small substitutions independently of
the amino terminal region. XL1(pMRK1.51) with substitution 259IIDKT and
XL1(pMRK1.52) with substitution 267TAYF were more efficient in gelatin
degradation than Pla (Fig 7B in IV).
The Pla/PgtE hybrids harbouring the amino acids 161HGVRGIGYS from the L3
area of PgtE processed proMMP-9 significantly more efficiently than Pla did.
This was seen with XL1(pMRK1.32) (Fig 7B and 7C in IV), XL1(pMRK1132)
(Fig  7A  and  7C  in  IV)  and  XL1(pMRK113)  including  L1  and  amino  acids
149IYDNGRYI and 161HGVRGIGYS from PgtE (Fig 7A and 7C in IV). Also L5
together  with  L1  was  found  to  be  important  in  proMMP-9  activation  and
XL1(pMRK115) generated active MMP-9 even more efficiently than PgtE (Fig
7A and 7C in IV). These results suggest that the sequence 161HGVRGIGYS from
the L3 area, together with L1, is important in proMMP-9 activation. The results
also show the significance of L5 in turning Pla into a PgtE-like proMMP-9
activator.
Figure 6. Schematic model and substitution strategy of Pla. The gray boxes denote ?-strand
regions and the white boxes L1 through L5 denote the outermost regions of the five surface loops.
The individual residues, as well as the larger regions substituted in Pla with the corresponding
PgtE sequence are indicated. The numbers refer to residues in the mature proteins, and the
sequence of Pla is given above the sequence of PgtE.
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In our substitution analysis, all of the non-identical amino acids between Pla and
PgtE were covered by large substitutions (Fig 6). The expression levels of the
hybrid proteins in the E. coli XL1 host were analyzed by anti-Pla and anti-PgtE
antisera and found to be essentially similar (Fig 6D in IV and data not shown).
The proteolytic activity of the hybrids was confirmed in Plg activation assay and
all hybrids, excluding pMRK1151, were at least as efficient in plasmin
formation as PgtE (Fig 6E in IV). XL1(pMRK1151) was inefficient in gelatin
degradation, proMMP-9 activation and Plg activation, and we think that in this
mutant the orientation of Ile259 and Thr263 residues somehow disturbs the
catalytically important amino acids Asp206 and His208 and therefore the
proteolytic activity of this mutant is prevented. Interestingly, the L3-associated
substitutions that increased proMMP-9 activation in Pla, decreased the Plg
activation to the level seen with PgtE (Fig 6E in IV and data not shown).
In summary, the results show that PgtE of S. enterica and Pla of Y. pestis differ
in their substrate specifities and that the sequence differences at the surface
loops are responsible for these differences. Pla has adapted to efficiently activate
Plg and PgtE to be a gelatin degrading and proMMP-9 activating enzyme. Pla
could  be  converted  into  a  gelatinase  by  relatively  small  substitutions,  such  as
two amino acid change in L5 (pMRK1.51), and substitutions of 27 amino acids
in L1 and L5 (pMRK115) converted Pla into a more efficient gelatinase than
wild-type  PgtE.  Our  results  suggest  the  important  role  of  L1  and  L5  for
gelatinolytic activity of PgtE and L1, L5 and L3 in proMMP-9 activation.
Different substrate specifities of Pla and PgtE probably reflect the different
pathogenic mechanisms that Salmonella and Y. pestis utilize to cause disease. Y.
pestis disseminates mainly extracellularly (Perry and Fetherston, 1997) and
activates circulating Plg efficiently, thus promoting the plasmin-mediated
degradation of ECM components (Lähteenmäki et al, 2005). Plasmin activates
several  proMMPs,  and  therefore  Pla-generated  plasmin  is  able  to  promote  a
sufficient amount of collagen and gelatin degradation for infection to proceed.
Recently, Lathem et al (2007) showed that Plg activation activity of Pla is
essential for Y. pestis in pneumonic plague, which indicates that the Pla-
mediated interference with the Plg system promotes the virulence of Y. pestis.
Salmonella is a facultatively intracellular pathogen and M?s are important host
cells for the migration of Salmonella.  The M?s secrete proMMP-9 as response
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to Salmonella LPS (Xie et al, 1994) and our results suggest that PgtE has
adapted to activate proMMP-9 secreted by M?s and also directly degrade
gelatin  of  ECM.  This  way Salmonella can compensate its weaker ability to
function as Plg activator as compared to Y. pestis.
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10. Conclusions
PgtE of S. enterica is a broad-spectrum outer membrane protease that activates
Plg, inactivates ?2AP, mediates serum resistance by degrading the complement
components C3b, C4b and C5, degrades gelatin, activates proMMP-9, degrades
CAMPs and mediates bacterial adhesion onto BM. Salmonella is a facultatively
intracellular pathogen that has a complex pathogenesis involving extracellular
and intracellular phases in the epithelial cells and the phagocytes (Ohl and
Miller, 2001; Mastroeni and Sheppard, 2004). Salmonella has many virulence
factors important in bacterial entry and survival in the M? during the systemic
salmonellosis (Ohl and Miller, 2001), and we found that also PgtE promotes
survival of Salmonella within murine M?s and in mice in vivo. Taken together,
PgtE  is  multifunctional  in  nature  and  can  have  a  role  at  various  steps  in
salmonellosis (summarized in Fig 7).
Figure  7.  A  model  of  the  functions  of  PgtE  of S. enterica during systemic infection. In this
study,  PgtE  was  found  to  have  various  functions.  It  has  a  role  in  survival  of Salmonella within
M?s, mediates bacterial adhesion onto ECM, potentiates migration through tissue barriers and
also is important in bacterial resistance to serum.
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This work addresses the importance of the coordinated regulation of the surface
structures of Salmonella in different environments. Lipid A and core regions of
LPS are remodelled in response to CAMPs (Ernst et al, 2001) and regulation of
the O-antigen length is thought to be important in interaction of Salmonella with
complement and M?s (Murray et al, 2006). One of the major findings in this
PhD work is the dual interaction of omptins with LPS. We found that rough LPS
is  crucial  for  PgtE  and  Pla  functions  but  that  they  are  sterically  inhibited  by  a
full-length O-antigen. We propose that the full activity of Pla is a major benefit
for Y. pestis, which is genetically rough. On the other hand, virulent Salmonella
isolates have smooth LPS, and therefore the functions of PgtE had remained
cryptic before this work. A second major finding in this thesis work is that the
O-antigen length is reduced during the growth of Typhimurium within M?s at
the same time when the expression of PgtE is upregulated, which in a concert
lead to high PgtE-mediated proteolysis. Typhimurium multiplying inside M?s
alter the LPS structure in the other molecular aspects as well, and it remains an
interesting task to analyze how, e.g., the PhoP/Q-controlled substitutions of
phosphates in lipid A affect PgtE activity. Taken together, the results in this PhD
study stress that the induction of the efficient surface proteolysis in Y. pestis and
S. enterica is not a matter of the protease gene expression only but is dependent
on the over-all alteration of the surface architecture.
Another main finding in this thesis work is the description of how S. enterica sv
Typhimurium interferes with three important proteolytic systems of human, the
Plg and the MMP systems and the complement system. PgtE was also found to
mimic  mammalian  MMPs  in  many  functions.  PgtE  was  known  to  be  a  Plg
activator and was here shown to degrade and inactivate the main inhibitor of
plasmin, antiprotease ?2AP. This will lead to uncontrolled plasmin activity
during infection, and this study gave evidence that ?2AP inactivation is
important  in  the  M?-mediated plasmin formation. Our results show that PgtE
has a positive effect on growth of Salmonella in human serum and at early stages
of systemic infection, supporting the view that PgtE is specifically focused to
mediate the migration of Salmonella. The mechanisms of how S. enterica and Y.
pestis interact with the Plg and MMP systems are mechanistically different and
probably reflect their very different pathogenic mechanisms. Y. pestis is mainly
an extracellular pathogen, and Pla is needed for its spread from the subdermal
skin sites into the lymph nodes (Sodeinde et al, 1992), whereas systemic
Salmonella infection is thought to include infective cycles of phagocytes, where
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Salmonella is transiently released from M?s to infect new ones (Sheppard et al,
2003; Mastroeni and Sheppard, 2004). The M?s  utilize  the  Plg  system  and
MMPs in their migration (Vassalli et al, 1992), and Salmonella LPS induces the
secretion of proMMP-9 from M?s (Xie et al, 1994). Our finding that PgtE of
Salmonella activates proMMP-9 and promotes bacterial survival in mice in vivo
led to the hypothesis that PgtE could have an effect on M? motility and also has
a role in migration of Salmonella within M?s.  Recently,  a  mechanism of  M?
mobility involving the SrfH protein encoded by SPI-2 was proposed (Worley et
al, 2006), and it seems likely that multiple mechanisms exist to enhance the
migration of M? during salmonellosis.
The last part of this thesis work addressed the possible evolution of gelatinase
activity in the omptin ?-barrel and identification of active domains and regions
in the PgtE molecule. We found that Pla and PgtE, which are similar in structure
and 72% identical in sequences, differ in their substrate specificity in MMP-
associated functions. It has been proposed that Pla has evolved from PgtE
(Kukkonen and Korhonen, 2004), and earlier studies in this laboratory indicated
that sequences near or at the surface-exposed loops are important for target
protein specificity in omptin proteolysis (Kukkonen et al, 2001). In this study,
conversion of Pla into a PgtE-like gelatinase and proMMP-9 activator was
achieved by substitution of amino acids in L1, L3 and L5. This exemplifies how
differing functions can be created in a horizontally spread protein fold, i.e. the
omptin ?-barrel.
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